Emmanuele

Venanzi Rullo

Email:

emmanuele.venanzirullo@unime.it

ALTRE INFORMAZIONI

SSD: MED/17

Struttura:Dipartimento di Medicina Clinica e Sperimentale

Profilo: Ricercatori Legge 240/10 - t.det.

CURRICULUM

Curriculum Italiano
Curriculum Inglese

Curriculum

Curriculum vitae
Emmanuele Venanzi Rullo M.D. PhD

Viale della Libertà, 395, 98121, Messina (ME)

+39 0902213260

     +39 3496495453
evenanzirullo@gmail.com   evenanzirullo@unime.it
PEC: emmanuele.venanzirullo.bxsr@rc.omceo.it
https://it.linkedin.com/in/emmanuele-venanzi-rullo-88930343
Whatsapp +39 3496495453 CF  VNNMNL84S03H224V N° Ord. Med.RC8665 Cod. ENPAM 300331976Y000
Sex Male | Date of birth 11/03/1984 | Nationality Italian

WORK EXPERIENCE

                            April 2020 -              Infectious Diseases specialist physician

Ward of Infectious Diseases, University Hospital of Messina, Messina, Italy
Business or sector Infectious diseases specialist
                  December 2019 -              Researcher in Infectious Diseases (RTD-A)

University of Messina, Messina, Italy
Business or sector Medical research in Infectious diseases

   October 2019 - April 2020              Fellow researcher

University of Pennsylvania, Philadelphia, PA
Visiting PhD student working on HIV reservoir and latency Business orsector Medical research in Infectious diseases
May 2018 - September 2019           Visiting PhD student

University of Pennsylvania, Philadelphia, PA

Visiting PhD student working on HIV reservoir and latency Business orsector Medical research in Infectious diseases

                           2017 - 2018              Tutor and Teacher in a II level Master

University of Messina, Messina, Italy
Master: Hospital Infection control
Business or sector Medical research in Infectious diseases
October 2016 – September 2019       PhD student in Medical and Surgical Biotechnologies

Department of Infection Diseases of University Hospital “G. Martino” of Messina

Business or sector Medical research in Infectious diseases

January 2016 – June 2016     Visiting Fellow/ Resident Doctor, Consultant (Fungal Infections inimmunocompromised patients)

Institute Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain

Visiting Fellow at the University Hospital “Ramón y Cajal” during the residency course to conduct research ininfectious diseases.

Business or sector Medical research in Infectious diseases

, May 2015 – December 2015 Visiting Fellow/ Resident Doctor, Tropical Medicine, Madrid
Unidad de referencia nacional para Enfermedades Tropicales, Madrid, Spain

Visiting Fellow at the Unidad de referencia nacional para Enfermedades Tropicales dell’Hospital Universitario“Ramón y Cajal” during the residency course to conduct research in tropical diseases.

Business or sector Medical research in Tropical diseases.

January 2015 – May 2015 Visiting Fellow/ Resident Doctor, Consultant (Bacterial and virus infections inimmunocompromised patients), Madrid

Servicio de Enfermedades Infecciosas dell’Hospital Universitario “Ramón y Cajal”, Madrid, Spain

Visiting Fellow at the Servicio de Enfermedades Infecciosas dell’Hospital Universitario “Ramón y Cajal” duringthe residency course to do clinical activity as an infectious disease consultant.

Business or sector Clinical Medical activity in Infectious disease

June 2011 – December 2014 Resident/fellow in Infectious Diseases
Unit of Infectious Diseases of University Hospital “G. Martino” of Messina

Clinical training in Internal Medicine and Infectious Diseases, HIV clinic, as an infectious consultant at the Unit ofInfection Diseases of University Hospital “G. Martino” of Messina during the residency course in Infectious diseases.

Business or sector Clinical Medical activity in Infectious diseases

November 2010 – January 2011 Training Doctor
“Bianchi-Melacrinò-Morelli” Hospital, Reggio Calabria, Italy

Clinical training in the Urologic Oncology Department , in the Medical Oncology clinic, in the operating room of Urology Surgery at the “Bianchi-Melacrinò-Morelli” Hospital of Reggio Calabria.

Business or sector Clinical Medical training activity

May 2015 – June 2016     Volunteer Doctor, NGO Saludentreculturas e Dianova, Madrid, Spain

▪  Volunteer Doctor at the NGO Saludentreculturas, trainer task for health agencies and cultural mediators on health issues and infectious diseases silent and/or transmissible (Chagas disesas, HIV, hepatitis, STD, tuberculosis, etc...)
Business or sector Medical training activity

December 2010 and March 2015     Volunteer Doctor, Centre de Santé “C.S.B II ECAR Petites servantes du S. Coer”,Ambatondrazaka, Madagascar

▪  Clinical activity as a volunteer doctor at the dispensary of Ambatondrazaka, Madagascar. Business orsector Clinical Medical activity

EDUCATION AND TRAINING

November 2019 - November 2029    Italian National Scientific Qualification (ASN)

Qualified to tenure Associate Professor in Infectious Diseases, Italy
Business or sector University teacher in Infectious diseases
    October 2016 - September 2019    PhD in Biotechnology Medical and Surgical

University of Messina, Messina, Italy
PhD student working on HIV reservoir and latency Business or sectorMedical research in Infectious diseases
June 2011 – June 2016     Diploma of Specialization in Infectious Diseases

University of Palermo, Faculty of Medicine and Surgery, School of Specialization in Infectious Diseases
▪  50 cum laude/50

Thesis: “Invasive pulmonary aspergillosis: new diagnostic and therapeutically perspectives”

December 2014 Diploma of habilitation in medical practice - Homologación al titulo españolde Licenciado en Medicina y Cirugía

Ministerio de educación, cultura y deporte, Subdirección general de titulos y reconocimiento de cualificaciones.

▪  Validation and habilitation in medical practice in Spain.

November 2010- February 2011        Diploma of habilitation in medical practice
University of Messina, Faculty of Medicine and Surgery
▪  Evaluation: 269/270

October 2003 – October 2010        Degree in Medicine and Surgery
University of Messina, Faculty of Medicine and Surgery
▪  Evaluation: 106/107

Thesis: “Surgical site infections”

PERSONAL SKILLS

UNDERSTANDING		SPEAKING		WRITING
Listening	Reading	Spoken interaction	Spoken production

Mother tongue(s)     Italian Other language(s)
Spanish                C2                      C2                     C2                      C1                     C1

English                B2                      B2                     B2                      B2                      B2

France                             A2                    A2                        A2                    A2                      A2

Communication skills

▪ I have good communication skills gained through my experience as a volunteer in different NGO that working with migrant population for the training ofcultural mediators and health agent

Digital skills SELF-ASSESSMENT

Informationprocessing	Communication	Contentcreation	Safety	Problemsolving
Independent user	Independent user	Independent user	Independent user	Independent user

Levels: Basic user - Independent user - Proficient user Digital competences -Self-assessment grid

ADDITIONAL INFORMATION

Publications

•                Pavone P et al. SARS-CoV-2 related Paediatric Acute-onset Neuropsychiatric Syndrome Lancet Child Adolesc Health. 2021 May 4; Online ahead of print
•                Marino A et al. Entecavir resistance in a patient with treatment-naïve HBV: A case report Mol Clin Oncol. 2021 Jun;14(6):113
•                Ceccarelli M. et al. Comment on safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: a nationwide comparative analysis Eur Rev Med Pharmacol Sci. 2021 Mar;25(6):2473-2474
•                Bonaccorsi I et al. HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk Immunol Lett. 2021 Apr 24;234:44-46.  Online ahead of print.
•                Pampaloni A et al. “Diagnosis on the Dock” project: a proactive screening program for diagnosing pulmonary tuberculosis in disembarking refugees and new SEI model. Int. J. Infect. Dis. 15, 2021 Mar 15;106:98-104
•                Cutroneo P et al. Psoriasis and psoriasiform reactions secondary to immune checkpoint inhibitors. Dermatol Ther 2021;:e14830.
•                Pirisi M et al. Liver infection and COVID-19: the electron microscopy proof and revision of the literature. Eur Rev Med Pharmacol Sci2021;25(4):2146–2151.
•                Guarneri C et al. Silent COVID-19: what your skin can reveal. The Lancet Infectious Diseases 2021;21(1):24–25.
•                Ceccarelli M et al. New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection. Dermatol Ther 2021;34(1):e14660.
•                Meduri A et al. Ocular surface manifestation of COVID-19 and tear film analysis. Sci Rep 2020;10(1):20178–7.
•                Venanzi Rullo E et al. Persistence of an intact HIV reservoir in phenotypically naive T cells. JCI Insight 2020;5(20):105.
•                Guarneri C et al. Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19. J Eur Acad Dermatol Venereol 2020;34(9):e449–e450.
•                Vella F et al. Transmission mode associated with coronavirus disease 2019: a review. Eur Rev Med Pharmacol Sci 2020;24(14):7889–7904.
•                Ceccarelli M et al. Editorial - Coronavirus disease 2019 and people living with HIV: clinical considerations. Eur Rev Med Pharmacol Sci2020;24(13):7534–7539.
•                Ceccarelli M et al. Non-AIDS defining cancers: a comprehensive update on diagnosis and management. Eur Rev Med Pharmacol Sci2020;24(7):3849–3875.
•                D'Andrea F et al. Hepatitis B virus infection and hepatocellular carcinoma in PLWH: epidemiology, pathogenesis and treatment[Internet]. World Cancer Research Journal 2020;(7):e1537.
•                Ceccarelli M, Berretta M, Venanzi Rullo E, Nunnari G, Cacopardo B. Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet? Eur Rev Med Pharmacol Sci2020;24(5):2781–2783.
•                D'Andrea F et al. Epstein Barr Virus related cancer in people living with HIV: a review of the literature. World Cancer Research Journal2020;(7):e1512.
•                Cannon L, Pinzone M, Venanzi Rullo E, O'Doherty U. Longitudinal sequencing reveals multiphasic decay of HIV reservoir. J Virus Erad2019;5:30.
•                Venanzi Rullo E et al. Genetic Evidence That Naive T Cells Can Contribute Significantly to the Human Immunodeficiency Virus Intact Reservoir: Time to Re-evaluate Their Role. Clin. Infect. Dis. 2019;69(12):2236–2237.
•                Facciolà A et al. Malignant melanoma in HIV: Epidemiology, pathogenesis, and management. Dermatol Ther 2019;:e13180.
•                D'Andrea F et al. Vaccines against HPV in people living with HIV: a review. World Cancer Research Journal 2019;(6):1–7.
•                D'Aleo F, Ceccarelli M, Venanzi Rullo E, Pellicanò GF, Nunnari G. Anal cancer in people living with HIV: the importance of the screening and of early diagnosis. World Cancer Research Journal 2019;:1–9.
•                Facciolà A et al. Hodgkin’s lymphoma in people living with HIV: epidemiology and clinical management. World Cancer Research Journal 2019;6(1):e1295.
•                D'Andrea F, Pellicanò GF, Venanzi Rullo E, Nunnari G, Ceccarelli M. Cervical cancer in women living with HIV: a review of the literature. World Cancer Research Journal 2019;:1–6.
•                Pinzone MR et al. Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion.2019;10(1):728.
•                D'Andrea F, Ceccarelli M, Facciolà A, Nunnari G, Pellicanò GF. Breast cancer in women living with HIV. Eur Rev Med Pharmacol Sci2019;23(3):1158–1164.
•                Pinzone MR et al. Circulating angiopoietin-like protein 2 levels are associated with decreased renal function in HIV+ subjects on cART: A potential marker of kidney disease. Biomed Rep 2019;10(2):140–144.
•                Facciolà A et al. The role of the hospital environment in the healthcare-associated infections: a general review of the literature. Eur Rev Med Pharmacol Sci 2019;23(3):1266–1278.
•                Venanzi Rullo E et al. Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors (Review). Mol Med Rep [published online ahead of print: January 10, 2019]; doi:10.3892/mmr.2019.9840
•                Ceccarelli M et al. The treatment of Kaposi’s sarcoma: Present and future options, a review of the literature. Eur Rev Med Pharmacol Sci 2019;23(17):7488–7497.
•                Venanzi Rullo E et al. Aerosolized Lipid Amphotericin B for Complementary Therapy and/or Secondary Prophylaxis in Patients with Invasive Pulmonary Aspergillosis: A Single-Center Experience. Mycopathologia 2019;184(2):239–250.
•                Cama BAV et al. Outbreak of Brucella melitensis infection in Eastern Sicily: risk factors, clinical characteristics and complication rate. New Microbiol. 2019;42(1):43–48.

Ceccarelli M, Venanzi Rullo E, Vaccaro M, et al. HIV-associated psoriasis: Epidemiology, pathogenesis, and management. Dermatol Ther.December 2018:e12806. doi:10.1111/dth.12806.
D'Andrea F, Paolucci IA, Ceccarelli M, et al. Pseudomonas aeruginosa detection in South Italy: an epidemiological survey. Infectious Diseases andTropical Medicine. 2018;4(4):e507.
Crespillo-Andújar C, Venanzi Rullo E, López-Vélez R, et al. Safety Profile of Benznidazole in the Treatment of Chronic Chagas Disease:Experience of a Referral Centre and Systematic Literature Review with Meta-Analysis. Drug Saf. 2018;41(11):1035-1048. doi:10.1007/s40264-018-0696-5.
D'Aleo F, Venanzi Rullo E, Paolucci IA, et al. Epidemiology of Klebsiella pneumoniae MDR during the years 2015-2017 in “G. Martino”University Hospital mof Messina: preliminary data. Infectious Diseases and Tropical Medicine. 2018;4(3):e488.
Cama BAV, Venanzi Rullo E, Condorelli F, et al. Nosocomial Citrobacter koseri urosepsis in an 87-year-old woman: a case-report. InfectiousDiseases and Tropical Medicine. 2018;4(3):e484.
Facciolà A, Ceccarelli M, Paolucci IA, et al. MRSA detection in South Italy: an epidemiological survey to evaluate the burden of this importantpublic health issue. Infectious Diseases and Tropical Medicine. 2018;4(3):e486.
Facciolà A, Ceccarelli M, Venanzi Rullo E, et al. Prostate cancer in HIV-positive patients- a review of the literature. World Cancer ResearchJournal. 2018;5(3):e1136.
Larnè D, Ceccarelli M, Condorelli F, Venanzi Rullo E, Nunnari G, Pellicanò GF. Bacteremic meningitis due to Pasteurella multocida resistant to firstline antibiotic therapy. Infect Dis Rep. 2018;10(2):7632–27. doi:10.4081/idr.2018.7632.
D'Aleo F, Ceccarelli M, Facciolà A, et al. Current fast methods for the identification of carbapenemase enzymes in clinical laboratory. InfectiousDiseases and Tropical Medicine. 2018;4(2):e470
Ceccarelli M, Venanzi Rullo E, Condorelli F, et al. Unusual Signs and Symptoms in HIV-Positive Patients Coinfected with Leishmania spp: The Importance of Neglected Tropical Disease in Differential Diagnosis. Open Access Maced J Med Sci. 2018;6(5):843-847. doi:10.3889/oamjms.2018.186.
Ceccarelli M, Venanzi Rullo E, Cama BAV, Pellicanò GF. Acute pericarditis during early-diagnosed Brucellosis: a case report. Infectious Diseasesand Tropical Medicine. 2018;4(1):e443.
D'Aleo F, Cama BAV, Paolucci IA, et al. New and old assumptions on lung cancer in People Living with HIV. World Cancer Research Journal.2018;5(1):e1036. http://www.wcrj.net/wp- content/uploads/sites/5/2018/03/e1036-New-and-old-assumptions-on-lung-cancer-in-People-Living- with-HIV.pdf.
Visalli G, Facciolà A, D'Aleo F, et al. HPV and urinary bladder carcinoma: a review of the literature. World Cancer Research Journal. 2018;5(1):e1038. http://www.wcrj.net/wp- content/uploads/sites/5/2018/03/e1038-HPV-and-urinary-bladder-carcinoma-a-review-of-the- literature.pdf.
Ceccarelli M, Venanzi Rullo E, Facciolà A, et al. Head and neck squamous cell carcinoma and its correlation with human papillomavirus in peopleliving with HIV: a systematic review. Oncotarget. 2018;9(24):17171-17180. doi:10.18632/oncotarget.24660.
Ceccarelli M, Venanzi Rullo E, Nunnari G. Risk factors of venous thrombo-embolism during cytomegalovirus infection in immunocompetentindividuals. A systematic review. Eur J Clin Microbiol Infect Dis. 2018;37(3):381-390. doi:10.1007/s10096-018-3185-y.
Atteritano M, Mirarchi L, Venanzi Rullo E, et al. Vitamin D Status and the Relationship with Bone Fragility Fractures in HIV-Infected Patients: ACase Control Study. international journal of molecular sciences. 2018;19(1). doi:10.3390/ijms19010119.
Ceccarelli M, Condorelli F, Venanzi Rullo E, Pellicanò GF. Improving access and adherence to screening tests for cancers: anew, though old,challenge in the hiv epidemics. World Cancer Research Journal. 2018;5(1):e1030. doi:10.1093/cid/ciu77

•                D'Andrea F et al. CANCER SCREENING IN HIV-INFECTED PATIENTS: EARLY DIAGNOSIS IN A HIGH-RISK POPULATION. World Cancer Research Journal 2018;5(3):e1130.
•                D'Aleo F et al. HIV AND COLORECTAL CANCER. NEW INSIGHTS AND REVIEW OF THE LITERATURE. World Cancer Research Journal 2018;5(3):e1122.
•                Larnè D, Pellicanò GF, Venanzi Rullo E, Ceccarelli M. High fecal calprotectin levels during lymph-nodal and abdominal tuberculosis. Infectious Diseases and Tropical Medicine 2017;3(4):E419.
•                Facciolà A et al. Kaposi's sarcoma in HIV-infected patients in the era of new antiretrovirals. Eur Rev Med Pharmacol Sci2017;21(24):5868–5869.
•                D'Aleo F et al. Hepatitis C-related hepatocellular carcinoma: diagnostic and therapeutic management in HIV-patients. Eur Rev Med Pharmacol Sci 2017;21(24):5859–5867.
•                Ceccarelli M et al. Hyponatremia following a cerebral abscess: cerebral salt wasting syndrome or syndrome of inappropriate anti-diuretic hormone secretion? Infectious Diseases and Tropical Medicine 2017;3(1):E362.
•                Venanzi Rullo E, Fortún J, Nunnari G. Diagnosing invasive pulmonary aspergillosis in COPD patients - more challenging and less rare than before. A review of the literature [Internet]. Infectious Diseases and Tropical Medicine 2016;2(4):e341–344.
•                Venanzi Rullo E, Lopez-Velez R. [Resistance to the antimalarial drugs]. Rev Esp Quimioter 2016;29 Suppl 1:72–75.
•                Venanzi Rullo E, Lopez-Velez R. [Current management of imported severe malaria]. Rev Esp Quimioter 2016;29 Suppl 1:66–71.
•                Fortún J et al. Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients. J. Infect. 2016;72(6):738–744.
•                Venanzi Rullo E, Crespillo C, López-Sanromán A, Fortún J. Pott’s disease after TNF-α inhibitors: a case report. Infectious Diseases and Tropical Medicine 2016;2(1):1–4.

Courses

Factores de riesgo y tasas de coinfección por hepatitis B y C en pacientes con infección VIH conocida en un área de alta incidencia (Yaoundé,Camerún). Crespillo C, Arias C, Gutiérrez A, García R, Rodríguez L, Berna C, De Chabot G, Risco C, Venanzi Rullo E, Antolín C, Velasco M. XXCongreso Nacional de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clinica

▪ Author of: Procedura per il controllo della diffusione intraospedaliera delle Enterobacteriaceae resistenti aicarbapenemi” dell’AOU G. Martino

Author of: “Linee guida del trattamento della malaria” della Unidad de Referencia Nacional para Enfermedades Tropicales. Servicio deEnfermedades Infecciosas. Hospital Universitario Ramón y Cajal, IRYCIS, Madrid

Corso precongressuale SIMPIOS. 19/05/2014
6° Congresso Nazionale SIMPIOS. 19-21/05/2014

▪ La Statistica In Medicina: Dalla Misurazione Degli Esiti Delle Cure Alle Pratiche Per L'assicurazione Della Qualita'. 5-7/06/2014

V Curso de Actualización en Patología infecciosa y antimicrobianos de uso clinico. 1-2/02/2015
XIII Jornada de Medicina del Viajero. 06/05/2015
XV Curso de Actualización en infección por VIH, 25-27/05/2015, 3.7 crediti
Rezolsta: sencillez y versatilidad en el tratamiento del VIH. 22/07/2015
Jornada Salud e interculturalidad, avances y retos. 02/12/2015
VI Curso de Actualización en Patología infecciosa y antimicrobianos de uso clinico. 1-2/02/2016
IV Jornada de actualización en Medicina tropical. 12/04/2016

▪ XX Congreso de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clinica. 26- 28/05/2016

XIV Jornada de Medicina del Viajero. 09/06/2016

▪ Patologia infettiva nel percorso di donazione e trapianto di organo solido, in termini di presentazione clinica, fattori di rischio, sorveglianza, prevenzione etrattamento di tutte le principali infezioni associate. (corso SIMIT) 1-2/09/2016
▪ Infezione/Malattia da virus dell’epatite B e dell’epatite C: aspetti pratici clinico-terapeutici per il medico specialista. 14-15/09/2016
▪ Finalista del “Under 40 Infection Lab - Final Contest” con comunicazione orale: “Amfotericina in aerosol per il trattamento dell’aspergillosi polmonareinvasiva, uno studio di coorte retrospettivo osservazionale” 29-30/09/2016

Corso di Eco color doppler per medici infettivologi, Bari 3-6/10/2016

▪ XV Congresso Nazionale della Società Italiana di Malattie Infettive e Tropicali, Baveno 16- 19/10/2016

Gestione Multidimensionale del Paziente con Infezione da HIV, Modena 7-9/11/2016
Atelier di stewardship antimicrobica (ASA), Pisa 5-6/12/2016
Antimicrobial stewardship e infection control il modello modenese, Modena 20-21/12/ 2016

▪ UMG meets the experts: International workshop on HIV/HCV research and cure, Catanzaro 02- 03/02/2017

AHEAD Achieving HEalth through Anti-infective Drugs, Roma 27-28/02/2017
3rd Annual Conference on the Selected Hot Topics of CROI, Bologna 01-02/03/2017
La gestione delle infezioni complicate nell’era della stewardship antibiotica relatore su “Meccanismi di resistenza batterici”, Messina21/04/2017
V Workshop on HIV & Hepatitis Co-infection, Palermo 4-6/05/2017
Corso di perfezionamento in terapia antiretrovirale, Roma 12-13/05/2017
VIII congresso regionale SIMIT, Catania 19-20/05/2017
XV Jornada de Medicina del Viajero, Madrid 07/06/2017
NextGen in infectious diseases, Firenze 14-15/12/18

Memberships Member SIMIT
Member SIMPIOS
Member SEIMC
Member SIMM

Curriculum

Curriculum vitae

Emmanuele Venanzi Rullo M.D. PhD

Viale della Libert., 395, 98121, Messina (ME)

+39 0902213260 +39 3496495453

evenanzirullo@gmail.com PEC: emmanuele.venanzirullo.bxsr@rc.omceo.it

https://it.linkedin.com/in/emmanuele-venanzi-rullo-88930343

Whatsapp +39 3496495453 CF VNNMNL84S03H224V

NÅã Ord. Med. RC8665 Cod. ENPAM 300331976Y000

Sex Male | Date of birth 11/03/1984 | Nationality Italian

WORK EXPERIENCE

April 2019 - Infectious Diseases specialist physician

Ward of Infectious Diseases, University Hospital of Messina, Messina, Italy

Business or sector Infectious diseases specialist

December 2019 - Researcher in Infectious Diseases

University of Messina, Messina, Italy